Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-03 8:44 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 32,489 | $252.85 | $8,214,998 | 22,410 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-25 Option Award | 2024-06-27 9:45 pm | N/A 2031-06-25 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 1,819 | $0 | 3,017 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-06 4:05 pm | N/A 2034-06-04 | Astria Therapeutics Inc. | ATXS | BATE KENNETH Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:44 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 10,000 | $9.45 | 22,410 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:44 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 32,489 | $0 | 22,410 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:44 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 10,000 | $100.45 | 22,410 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 8:44 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 12,489 | $105.08 | 22,410 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 6:41 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 1,198 | $0 | 1,198 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:00 am | N/A 2033-06-01 | Astria Therapeutics Inc. | ATXS | BATE KENNETH Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2023-01-19 Disposition | 2023-01-19 5:19 pm | N/A 2023-05-29 | AVEO PHARMACEUTICALS INC. | AVEO | BATE KENNETH Director | 68,202 | $0 | 375 (Direct) | View |
| 2023-01-19 Disposition | 2023-01-19 5:19 pm | N/A N/A | AVEO PHARMACEUTICALS INC. | AVEO | BATE KENNETH Director | 375 | $15 | 375 (Direct) | View |
| 2022-08-12 Disposition | 2022-08-16 6:55 pm | N/A N/A | Epizyme Inc. | EPZM | BATE KENNETH Director | 17,054 | $0 | 0 (Direct) | View |
| 2022-06-09 Option Award(A) | 2022-06-21 08:33 am | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | BATE KENNETH Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 06:30 am | N/A 2025-06-16 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 9,470 | $0 | 9,470 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-09 6:00 pm | N/A 2032-06-08 | Astria Therapeutics Inc. | ATXS | BATE KENNETH Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:58 pm | N/A 2032-06-06 | AVEO PHARMACEUTICALS INC. | AVEO | BATE KENNETH Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:30 pm | N/A 2032-05-16 | Epizyme Inc. | EPZM | BATE KENNETH Director | 50,000 | $0 | 58,060 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 11:54 am | 2022-07-01 2031-07-01 | GENOCEA BIOSCIENCES INC. | GNCA | BATE KENNETH Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 08:02 am | N/A 2024-06-17 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 12,489 | $0 | 12,489 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 4:41 pm | N/A 2031-06-10 | Epizyme Inc. | EPZM | BATE KENNETH Director | 48,619 | $0 | 48,619 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-09 5:17 pm | N/A 2031-06-08 | AVEO PHARMACEUTICALS INC. | AVEO | BATE KENNETH Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-02 7:16 pm | N/A 2031-06-01 | CATABASIS PHARMACEUTICALS INC | CATB | BATE KENNETH Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-30 4:34 pm | N/A 2030-06-09 | AVEO PHARMACEUTICALS INC. | AVEO | BATE KENNETH Director | 4,000 | $0 | 4,000 (Direct) | View |
| 2020-06-18 Option Award | 2020-06-19 4:12 pm | 2021-06-18 2030-06-18 | GENOCEA BIOSCIENCES INC. | GNCA | BATE KENNETH Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 07:46 am | N/A 2025-06-17 | MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-12 11:44 am | N/A 2030-06-10 | CATABASIS PHARMACEUTICALS INC | CATB | BATE KENNETH Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 4:15 pm | N/A 2030-05-28 | Epizyme Inc. | EPZM | BATE KENNETH Director | 14,013 | $0 | 14,013 (Direct) | View |